A/Prof Angela Devine is a Health Economist at Menzies School of Health Research and The University of Melbourne. Her current research focuses on the costs and cost-effectivene of strategies for the treatment and control of malaria. A large number of these studies are in Indonesia and Papua New Guinea. Other research interests include the valuation of productivity losses in unpaid populations and the use of online models to inform policy. Within ACREME, Angela leads a program of research evaluating the costs and cost-effectiveness of options for the treatment and control of malaria.Related Publications
- A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
- Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
- Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
- Economic costs of vivax malaria episodes: A multi-country comparative analysis using primary trial data
- Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
- Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) – A Multi-Centre, Open Label, Superiority Randomised Controlled Trial
- Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial
- Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
- Household costs associated with zoonotic Plasmodium knowlesi, P. falciparum, P. vivax and P. malariae infections in Sabah, Malaysia
- Longitudinal trends in malaria testing rates in the face of elimination in eastern Myanmar: a 7-year observational study
- Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
- Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset
- Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group
- Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
- Spatiotemporal trends in P. falciparum malaria and identification of high-risk villages in Eastern Myanmar: an 8-year observational study
- Surveillance to achieve malaria elimination in eastern Myanmar: a 7-year observational study
- Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model
- The household economic burden of human-only and zoonotic malaria, compared to other causes of acute febrile illness in Indonesia
- The impact of mass screening and treatment interventions on malaria incidence and prevalence: a retrospective analysis of a malaria elimination programme in eastern Myanmar, and systematic review and meta-analysis